Publication:
Pericardial effusion after streptokinase for acute myocardial infarction: An echocardiographic 1-year follow-up study

dc.contributor.authorOtasevic, Petar (55927970400)
dc.contributor.authorNeskovic, Aleksandar N. (35597744900)
dc.contributor.authorBojic, Milovan (7005865489)
dc.contributor.authorPopovic, Aleksandar D. (7005726330)
dc.date.accessioned2025-06-12T11:52:08Z
dc.date.available2025-06-12T11:52:08Z
dc.date.issued1997
dc.description.abstractSince the reported incidence of pericardial effusion following thrombolysis is highly variable, we have evaluated 80 consecutive patients with first acute myocardial infarction treated with streptokinase. Two-dimensional echocardiographic studies were performed on days 1,2,3, and 7, at 3 and 6 weeks, and 3, 6, and 12 months following acute myocardial infarction. Throughout the study, pericardial effusion was found in 7 of 80 (8.75%) patients, being small in 5 patients, moderate in 1 and large in 1 patient. No clinical, angiographic, or echocardiographic variable was associated with pericardial effusion formation. The incidence of pericardial effusion found in our study is almost three times lower than in other echocardiographic studies on pericardial effusion in thrombolysed patients. Whether this differences results from the beneficial effects of streptokinase is not clear. © 1997 S. Karger AG, Basel.
dc.identifier.urihttps://doi.org/10.1159/000177417
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-1842338657&doi=10.1159%2f000177417&partnerID=40&md5=ec5210798978d804ff557d95012f7945
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/1606
dc.subjectAcute myocardial infarction
dc.subjectPericardial effusion
dc.subjectThrombolysis
dc.titlePericardial effusion after streptokinase for acute myocardial infarction: An echocardiographic 1-year follow-up study
dspace.entity.typePublication

Files